The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases mortality rates in older adults and those with comorbidities. Individuals with certain comorbidities may have a poor immune response and require early booster vaccines. We aimed to assess the immune response after two doses of Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Porntharukchareon, Thachanun, Chartisathian, Wipada, Navinpipat, Manassamon, Samdaengpan, Chayanee, Cheirsilpa, Kunsuda, Lueprasitsakul, Aimwipa, Worawichawong, Supanat, Muangsillapasart, Viroj, Pumuthaivirat, Pratya, Dechates, Bothamai, Sirisreetreerux, Supamas, Siripongboonsitti, Taweegrit, Rangsrisaeneepitak, Vimonsri, Jirawattanapalin, Kerati, Tawinprai, Kriangkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484043/
https://www.ncbi.nlm.nih.gov/pubmed/37671943
http://dx.doi.org/10.1080/21645515.2023.2251850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484043/
https://www.ncbi.nlm.nih.gov/pubmed/37671943
http://dx.doi.org/10.1080/21645515.2023.2251850

Ejemplares similares